GE chief sells biopharma business for $21 billion
- 25-Feb-2019
Shares of General Electric surged 11 percent on Monday after the U.S. industrial conglomerate said it would sell its biopharma business to Danaher Corp for $21 billion
Friday, April 17, 2026
biopharma business